Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-008125

Chief Financial Officer sold 1,781 shares at $14.21 ($25,308)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2020-02-06 Sale −1,781 $14.21 $25,308 72,282 D: show line 1 in the form
Open-market sales · 1,781 sh · avg $14.21 · $25,308
Loading xslF345X03/doc4.xml…